Unaltered T cell responses to common antigens in individuals with Parkinson’s disease
暂无分享,去创建一个
A. Sette | D. Sulzer | D. Standaert | I. Litvan | D. Weiskopf | A. Grifoni | J. Goldman | C. L. Lindestam Arlehamn | J. Mateus | A. Frazier | K. Muskat | R. Alcalay | R. da Silva Antunes | A. Amara | Gregory P. Williams | Yaqian Xu | G. Williams | Ricardo da Silva Antunes
[1] S. Elledge,et al. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis , 2022, Science.
[2] Mark M. Davis,et al. CD4+ T cells contribute to neurodegeneration in Lewy body dementia , 2021, Science.
[3] Wei Yang,et al. Dysregulation of the Adaptive Immune System in Patients With Early-Stage Parkinson Disease , 2021, Neurology: Neuroimmunology & Neuroinflammation.
[4] M. Mittelbrunn,et al. The role of T cells in age-related diseases , 2021, Nature Reviews Immunology.
[5] Sonja W. Scholz,et al. Challenges in the diagnosis of Parkinson's disease , 2021, The Lancet Neurology.
[6] Samantha M. Carlisle,et al. Sex-based differences in the activation of peripheral blood monocytes in early Parkinson disease , 2021, NPJ Parkinson's disease.
[7] A. Sette,et al. Differential T-Cell Reactivity to Endemic Coronaviruses and SARS-CoV-2 in Community and Health Care Workers , 2021, The Journal of infectious diseases.
[8] Bjoern Peters,et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection , 2021, Science.
[9] A. Sette,et al. Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4+ T Cells in COVID-19 , 2020, Cell.
[10] S. Mallal,et al. Identification and Characterization of CD4+ T Cell Epitopes after Shingrix Vaccination , 2020, Journal of Virology.
[11] J. Greenbaum,et al. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals , 2020, Cell.
[12] Sandeep Kumar Dhanda,et al. Development and Validation of a Bordetella pertussis Whole-Genome Screening Strategy , 2020, Journal of immunology research.
[13] R. Scheuermann,et al. A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2 , 2020, Cell Host & Microbe.
[14] Zachary D. Wallen,et al. Innate and adaptive immune responses in Parkinson's disease. , 2020, Progress in brain research.
[15] D. Berg,et al. Alterations in Blood Monocyte Functions in Parkinson's Disease , 2019, Movement disorders : official journal of the Movement Disorder Society.
[16] R. Scheuermann,et al. A survey of known immune epitopes in the enteroviruses strains associated with acute flaccid myelitis. , 2019, Human immunology.
[17] P. Iwanowski,et al. Infectious Etiologies of Parkinsonism: Pathomechanisms and Clinical Implications , 2019, Front. Neurol..
[18] Morten Nielsen,et al. IEDB-AR: immune epitope database—analysis resource in 2019 , 2019, Nucleic Acids Res..
[19] S. Kügler,et al. β-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration , 2019, Nature.
[20] M. Dubinsky,et al. Anti–Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease , 2018, JAMA neurology.
[21] Gene W. Yeo,et al. Th17 Lymphocytes Induce Neuronal Cell Death in a Human iPSC-Based Model of Parkinson's Disease. , 2018, Cell stem cell.
[22] D. Kaufmann,et al. Comparative analysis of activation induced marker (AIM) assays for sensitive identification of antigen-specific CD4 T cells , 2017, PloS one.
[23] S. Mallal,et al. T cells of Parkinson’s disease patients recognize α–synuclein peptides , 2017, Nature.
[24] Manoj Kumar,et al. INGE GRUNDKE-IQBAL AWARD FOR ALZHEIMER’S RESEARCH: NEUROTOXIC REACTIVE ASTROCYTES ARE INDUCED BY ACTIVATED MICROGLIA , 2019, Alzheimer's & Dementia.
[25] S. Mallal,et al. Definition of Human Epitopes Recognized in Tetanus Toxoid and Development of an Assay Strategy to Detect Ex Vivo Tetanus CD4+ T Cell Responses , 2017, PloS one.
[26] Alessandro Sette,et al. A Cytokine-Independent Approach To Identify Antigen-Specific Human Germinal Center T Follicular Helper Cells and Rare Antigen-Specific CD4+ T Cells in Blood , 2016, The Journal of Immunology.
[27] J. Woulfe,et al. Human serum antibodies against EBV latent membrane protein 1 cross-react with α-synuclein , 2016, Neurology: Neuroimmunology & Neuroinflammation.
[28] Bjoern Peters,et al. Automatic Generation of Validated Specific Epitope Sets , 2015, Journal of immunology research.
[29] M. Okun,et al. The Demise of Poskanzer and Schwab's Influenza Theory on the Pathogenesis of Parkinson's Disease , 2013, Parkinson's disease.
[30] Kosloski,et al. CD4+ Regulatory and Effector/Memory T Cell Subsets Profile Motor Dysfunction in Parkinson’s Disease , 2012, Journal of Neuroimmune Pharmacology.
[31] K. Teschke,et al. Association of Parkinson's disease with infections and occupational exposure to possible vectors , 2012, Movement disorders : official journal of the Movement Disorder Society.
[32] A. Espay,et al. Postencephalitic parkinsonism and basal ganglia necrosis due to Epstein-Barr virus infection , 2011, Neurology.
[33] S. Toovey,et al. Parkinson’s disease or Parkinson symptoms following seasonal influenza , 2011, Influenza and other respiratory viruses.
[34] E. Hirsch,et al. Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. , 2008, The Journal of clinical investigation.
[35] Houeto Jean-Luc. [Parkinson's disease]. , 2022, La Revue du praticien.
[36] S. Ambrosio,et al. Lymphocyte populations in Parkinson’s disease and in rat models of parkinsonism , 2001, Journal of Neuroimmunology.
[37] J. Fleming,et al. Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson's disease , 2004, Movement disorders : official journal of the Movement Disorder Society.
[38] P. Mcgeer,et al. Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains , 1988, Neurology.
[39] P. Fishman,et al. Infection of the basal ganglia by a murine coronavirus. , 1985, Science.
[40] R. Schwab,et al. COHORT ANALYSIS OF PARKINSON'S SYNDROME: EVIDENCE FOR A SINGLE ETIOLOGY RELATED TO SUBCLINICAL INFECTION ABOUT 1920. , 1963, Journal of chronic diseases.